109 related articles for article (PubMed ID: 15499989)
41. Expression of tumor necrosis factor-like weak inducer of apoptosis in human middle ear cholesteatoma.
Park M; Lee B; Lee J
ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):221-7. PubMed ID: 23900149
[TBL] [Abstract][Full Text] [Related]
42. [Expression of matrix metalloproteinasa-2,9 in cholesteatoma and middle ear cancer].
Zhu W; Xie Y; Wang P
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):119-22. PubMed ID: 12761978
[TBL] [Abstract][Full Text] [Related]
43. [Study of long non-coding RNA HOTAIR expression in middle ear cholesteatoma].
Li Q; Wang HQ; Chen YQ; Xiong S; Zeng L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):250-253. PubMed ID: 29871236
[No Abstract] [Full Text] [Related]
44. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
Liu Y; Cui Y; Yu L; Zhang P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
[TBL] [Abstract][Full Text] [Related]
45. Micronucleus frequency in acquired middle ear cholesteatoma.
Oztürk K; Yildirim MS; Acar H; Arikoğlu H; Arbağ H; Ozer B
Acta Otolaryngol; 2004 Oct; 124(8):924-8. PubMed ID: 15513528
[TBL] [Abstract][Full Text] [Related]
46. The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas.
Sheikholeslam-Zadeh R; Decaestecker C; Delbrouck C; Danguy A; Salmon I; Zick Y; Kaltner H; Hassid S; Gabius HJ; Kiss R; Choufani G
Laryngoscope; 2001 Jun; 111(6):1042-7. PubMed ID: 11404618
[TBL] [Abstract][Full Text] [Related]
47. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis.
Xu XC; Wong WY; Goldberg L; Baer SC; Wolf JE; Ramsdell WM; Alberts DS; Lippman SM; Lotan R
Cancer Res; 2001 Jun; 61(11):4306-10. PubMed ID: 11389049
[TBL] [Abstract][Full Text] [Related]
48. Expression of retinoid receptors in sebaceous cell carcinoma.
Chakravarti N; El-Naggar AK; Lotan R; Anderson J; Diwan AH; Saadati HG; Diba R; Prieto VG; Esmaeli B
J Cutan Pathol; 2006 Jan; 33(1):10-7. PubMed ID: 16441406
[TBL] [Abstract][Full Text] [Related]
49. Expressions of isopeptide bonds and corneodesmosin in middle ear cholesteatoma.
Koizumi H; Kawaguchi R; Ohkubo JI; Ikezaki S; Kitamura T; Hohchi N; Hashida K; Suzuki H
Clin Otolaryngol; 2017 Apr; 42(2):252-262. PubMed ID: 27390311
[TBL] [Abstract][Full Text] [Related]
50. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
Raynov AM; Moon SK; Choung YH; Hong SP; Park K
Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
[TBL] [Abstract][Full Text] [Related]
51. [DNA character of the cholesteatoma].
Cui Y; Pan H; Gao Q
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):62-3. PubMed ID: 12541864
[TBL] [Abstract][Full Text] [Related]
52. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
Wang H; Xu Z; Tang A; Su J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
[TBL] [Abstract][Full Text] [Related]
53. Expression of RANKL and OPG in middle ear cholesteatoma tissue.
Jeong JH; Park CW; Tae K; Lee SH; Shin DH; Kim KR; Park YW
Laryngoscope; 2006 Jul; 116(7):1180-4. PubMed ID: 16826057
[TBL] [Abstract][Full Text] [Related]
54. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention.
Shin DM; Xu XC; Lippman SM; Lee JJ; Lee JS; Batsakis JG; Ro JY; Martin JW; Hittelman WN; Lotan R; Hong WK
Clin Cancer Res; 1997 Jun; 3(6):875-80. PubMed ID: 9815762
[TBL] [Abstract][Full Text] [Related]
55. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
[TBL] [Abstract][Full Text] [Related]
56. [Keratinocyte growth factor and its receptor in middle-ear cholesteatoma].
Guzińska-Ustymowicz K; Kurzyna A; Trzpis K; Kemona A; Hassmann-Poznańska E
Otolaryngol Pol; 2013; 67(2):67-71. PubMed ID: 23452652
[TBL] [Abstract][Full Text] [Related]
57. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
58. [Expression of human papillomavirus DNA in cholesteatoma of the middle ear].
Bai Y; Yan L; Li S; Bai Q
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Oct; 35(5):352-5. PubMed ID: 12768735
[TBL] [Abstract][Full Text] [Related]
59. E-cadherin expression in acquired cholesteatoma.
Erdoglija M; Milanovic N; Colic M; Jovic M
B-ENT; 2013; 9(3):241-6. PubMed ID: 24273956
[TBL] [Abstract][Full Text] [Related]
60. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
